Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Sesin Kocagoz"'
Publikováno v:
Turkish Journal of Vascular Surgery, Vol 29, Iss 3, Pp 222-3 (2020)
None [Turk J Vasc Surg 2020; 29(3.000): 222-3]
Externí odkaz:
https://doaj.org/article/6e7dd76705f44d0582cd0aea7775dd03
Autor:
Cansu Hemsinlioglu, Nil Banu Pelit, Omur Selin Gunaydin, Nihal Ozturk Sahin, Esra Savas Karagacli, Sefa Onur Demir, Evren Safak, Raife Dilek Turan, Goncagul Celebi, Miyase Ezgi Kocaoglu Sen, Zeynep Torun, Utku Seyis, Rehile Zengin, Ayse Sesin Kocagoz, Caglar Cuhadaroglu, Nur Birgen, Siret Ratip, Ercument Ovali
BACKGROUND The efficacy of SARS-CoV2 single donor convalescent plasma (CP) varied according to the application time and the amount of antibody that is administered. Single donor CP has some drawbacks; such as the insufficient levels of neutralizing a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b3286eaecda19042444d50d795e508c
https://doi.org/10.21203/rs.3.rs-1042702/v3
https://doi.org/10.21203/rs.3.rs-1042702/v3
Autor:
Aysun Isiklar, Gul Basaran, Beyza Sepin, Ozge Gumusay, Ayse Sesin Kocagoz, Caglar Cuhadaroglu
Publikováno v:
Journal of Oncology Pharmacy Practice. 29:484-488
Background Interstitial lung disease interstitial lung disease is a group of respiratory diseases that causes progressive fibrosis. Many of the recently approved oncology drugs are associated with the development of interstitial lung disease as an ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00e6cd96c6bcffd2f20f44db7cbcccf3
https://doi.org/10.1177/10781552221107532
https://doi.org/10.1177/10781552221107532
Autor:
Ali Mert, Okan Derin, Halis Akalın, Rıdvan Dumlu, Sibel Gündeş, Rehile Zengin, Sesin Kocagöz, Yasemin Gündoğdu, İftihar Köksal, Demet Yalçın, Cemal Üstün, Mahir Kapmaz, Levent Görenek, Kadriye Karahangil, Füsun Can, Consortium, Önder Ergönül
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-7 (2024)
Abstract Data in the literature on the use of ceftazidime-avibactam (CAZ-AVI) in carbapenem-resistant Klebsiella pneumoniae bloodstream infections (CRKP-BSIs) are limited especially in OXA-48 (Oxacillinase-48) predominant regions. Our study aimed to
Externí odkaz:
https://doaj.org/article/0aa31e2079434237910d5a4d0ffefc3c
Autor:
Işıl Köylüoğlu, Achmet Ali, Zeynep Tuğçe Sarikaya, Merve Şeker, Rehile Zengin, Lerzan Doğan, Ararso Kedir Jima, Taner Ljama, Şaban Selçuk Dinçer, Fatma Elif Gülek, Murathan Yazici, Nilufer Celtik, Aykut Ayyildiz, Ismail Demirel, Canan Akinci, Filiz Tuzuner, Hande Simten Demirel Kaya, Sevdinaz Rasimoğlu, Vildan Ersoz, Meltem Yonca Eren, Ayse Sesin Kocagoz, Duygu Emine Güdük, Özkan İbrahim Akinci, İbrahim H. Dikmen, Isil Kesimci, İlkay Kısa Özdemir, A. Serkan Ünsal, Mustafa Şener Yildirim, Aylin Ilksoz, Şahika Bolsoy Deveci, Emir Kilinç, Seher İrem Kiran, Orkhan Mammadov
Publikováno v:
Türk Yoğun Bakım Dergisi, Vol 18, Iss 1, Pp 1-13 (2020)
Objective:The number of patients with COVID-19 has rapidly increased, thereby exceeding the capacities of health systems and causing serious losses in affected countries because of the rapid spreading potential, high virulence, and lack of vaccine an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f940bc3b08556c5773e24241257b9b60
https://doaj.org/article/95cec2af4dd54ba1b7ffd707301b453a
https://doaj.org/article/95cec2af4dd54ba1b7ffd707301b453a
Autor:
Ridvan Dumlu, Canan Hasanoglu, Caglar Cuhadaroglu, Birsen Mutlu, Mehmet Polatli, Ayhan Ozhasenekler, Ömer Karaşahin, Turhan Togan, Oğuz Kilinç, Firdevs Aksoy, Hakan Kati, Selami Ekin, Iftihar Koksal, Derya Yapar, Hakan Günen, Sebnem Eren Gok, Rahmet Guner, Alper Şener, Ayse Odemis, Esin Şenol, Nurdan Kokturk, Abdullah Sayiner, Ayse Sesin Kocagoz, Nurgül Sevimli, Yeşim Yıldız, Nurcan Baykam, AyŞe FÜsun TopÇu, Aykut Cilli, Huseyin Arpag
Publikováno v:
Turk Thorac J
OBJECTIVE: To evaluate the rate of pneumococcal pneumonia (PP) among patients with community-acquired pneumonia (CAP) in Turkey and to investigate and compare features of PP and non-PP CAP patients. MATERIAL AND METHODS: This multicenter, non-interve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4359e3a39125f9c0b94172ed0a57b194
https://pubmed.ncbi.nlm.nih.gov/35110252
https://pubmed.ncbi.nlm.nih.gov/35110252
OBJECTIVE COVID-19 pandemic has placed an unprecedented burden on health-care system. Patients with cancer are reported to have a higher risk of infection and a more complicated COVID-19 course. Breast cancer (BC) is the most common cancer in women i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87ccbb4ca84dc5214bf058311a7cf3e4
https://doi.org/10.5505/tjo.2022.3692
https://doi.org/10.5505/tjo.2022.3692
Autor:
Ozden Hatirnaz Ng, Sezer Akyoney, Ilayda Sahin, Huseyin Okan Soykam, Gunseli Bayram Akcapinar, Ozkan Ozdemir, Derya Dilek Kancagi, Gozde Sir Karakus, Bulut Yurtsever, Ayse Sesin Kocagoz, Ercument Ovali, Ugur Ozbek
Publikováno v:
PLoS ONE
PLoS ONE, Vol 16, Iss 12, p e0260438 (2021)
PLoS ONE, Vol 16, Iss 12 (2021)
PLoS ONE, Vol 16, Iss 12, p e0260438 (2021)
PLoS ONE, Vol 16, Iss 12 (2021)
The Coronavirus Disease 2019 (COVID-19) was declared a pandemic in March 2020 by the World Health Organization (WHO). As of May 25th, 2021 there were 2.059.941 SARS-COV2 genome sequences that have been submitted to the GISAID database, with numerous
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5adc02b45c460d926acee857076bf17b
http://europepmc.org/articles/PMC8648120
http://europepmc.org/articles/PMC8648120
Autor:
Raife Dilek Turan, Omur Selin Gunaydin, Muhammer Elek, Nil Banu Pelit, Ercument Ovali, Sefa Onur Demir, Rehile Zengin, Miyase Ezgi Kocaoglu, Cihan Tastan, Nur Birgen, Nihal Ozturk Sahin, Selen Abanuz, Esra Savas Karagacli, Caglar Cuhadaroglu, Goncagul Celebi, Bulut Yurtsever, Derya Dilek Kancagi, Cansu Hemsinlioglu, Gozde Sir Karakus, Koray Yalcin, Evren Safak, Ayse Sesin Kocagoz, Siret Ratip, Zeynep Torun, Omer Elibol, Didem Cakirsoy, Utku Seyis
Introduction The efficacy of SARS-CoV2 standard single donor convalescent plasma varied according to the application time and most importantly the amount of antibody that is administered. Single donor plasma has some drawbacks; such as the insufficie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::10f5eff4215dd3b7996e4caf620d74dc
https://doi.org/10.21203/rs.3.rs-1042702/v1
https://doi.org/10.21203/rs.3.rs-1042702/v1
Autor:
Cansu Hemsinlioglu, Nil Banu Pelit, Koray Yalcin, Omur Selin Gunaydın, Nihal Ozturk Sahin, Esra Savas Karagacli, Omer Elibol, Sefa Onur Demir, Evren Safak, Raife Dilek Turan, Goncagul Celebi, Miyase Ezgi Kocaoglu, Gozde Sir Karakus, Bulut Yurtsever, Cihan Tastan, Selen Abanuz, Didem Cakirsoy, Derya Dilek Kancagi, Zeynep Torun, Utku Seyis, Muhammer Elek, Rehile Zengin, Ayse Sesin Kocagoz, Caglar Cuhadaroglu, Nur Birgen, Siret Ratip, Ercument Ovali
IntroductionThe efficacy of SARS-CoV2 standard single donor convalescent plasma varied according to the application time and most importantly the amount of antibody that is administered. Single donor plasma has some drawbacks; such as the insufficien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::19814f32a500e48d0aeba4155ed87953
https://doi.org/10.1101/2021.03.05.21251413
https://doi.org/10.1101/2021.03.05.21251413